Title rated 0 out of 5 stars, based on 0 ratings(0 ratings)
eBook, 2012
Current format, eBook, 2012, , All copies in use.
eBook, 2012
Current format, eBook, 2012, , All copies in use. Offered in 0 more formats
This e-book is a reference on Selegiline (( - )-Deprenyl) effects on the brain. Selegiline, described in thousands of research papers, is registered in over 60 countries. At present, more than one hundred preparations containing selegiline circulate in the global market under different brand names. They are widely used in the treatment of Parkinson's disease, Alzheimer's disease, major depression and as a geroprotective / anti-aging drug. (( - )-Deprenyl) selegiline, the first selective inhibitor of B-type MAO which, in contrast to the known MAO inhibitors, did not potentiate the effect of tyra.
From the community